Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

ARO-ALK7

NCT06937203

Arrowhead · Phase 1/2 · Recruiting · Enrollment 150

NCT06937203

ArmNauseaVomitingDiarrheaDiscontinuationDeaths
Part 1 and Part 2 (optional cohort): ARO-ALK7n/rn/rn/rn/rn/r
Part 1 and Part 2 (optional cohort): Placebon/rn/rn/rn/rn/r
Part:2: ARO-ALK7 + Tirzepatiden/rn/rn/rn/rn/r
Part 2: Placebo + Tirzepatiden/rn/rn/rn/rn/r

A count stays a count. This page does not turn a count into a percent.